GGrantIndex
Sort

25,944 grants matching neurodegeneration

Expanding the set of genetically encoded tools for compartment-specific manipulation of redox metabolism in living cells

$480,000
Valentin Cracan · Scintillon Institute For Photobiology · R35 · FY2024 · GM

Expanding the set of genetically encoded tools for compartment-specific manipulation of redox metabolism in living cells

$480,000
Valentin Cracan · Scintillon Institute For Photobiology · R35 · FY2022 · GM

Mechanisms of mitochondrial disease suppression in Ndufs4 knockout mice

$479,711
Matt Kaeberlein · University Of Washington · R01 · FY2017 · NS

ApOE effects on neuron signaling and function via ApoER2

$479,477
G. William Rebeck · Georgetown University · R01 · FY2013 · AG

Novel Cognitive Markers of Early Alzheimer's Disease.

$479,414
Diane M. Jacobs · University Of California, San Diego · R01 · FY2021 · AG

Overcoming the Inhibitory Neurovascular Niche in Preterm Infant Brain Injury

$479,072
Mark A Petersen · University Of California, San Francisco · R01 · FY2023 · NS

Assembly and Dynamics of Molecular Machines in Genome Maintenance

$478,940
Maria Spies · University Of Iowa · R35 · FY2024 · GM

Assembly and Dynamics of Molecular Machines in Genome Maintenance

$478,940
Maria Spies · University Of Iowa · R35 · FY2025 · GM

Alternative vacuolar targeting mechanisms in yeast

$478,888
Daniel J. Klionsky · University Of Michigan At Ann Arbor · R01 · FY2007 · GM

Biomarker Core

$478,881
Sterling C Johnson · University Of Wisconsin-Madison · P30 · FY2022 · AG

Biomarker Core

$478,881
Sterling C Johnson · University Of Wisconsin-Madison · P30 · FY2023 · AG

Comprehensive Determination of Isoprostanoid Metabolism

$478,765
Ginger Lohr Milne · Vanderbilt University Medical Center · R21 · FY2024 · AG

History of Alzheimer predisposes children to amyloid beta-related hypometabolism

$478,649
Lisa Mosconi · New York University School Of Medicine · R01 · FY2013 · AG

Developing cross-platform fluorescent reporters for measuring the 26S proteasome and the VCP activities

$478,624
Ying Lu · Harvard Medical School · R21 · FY2025 · AG

Contributions of educational quality and occupational complexity on racial and ethnic inequities in brain health and Alzheimer's disease and related dementia

$478,456
Paola Gilsanz · Kaiser Foundation Research Institute · R01 · FY2020 · AG

How do synaptic connections change in demyelinating disease?

$478,224
Dorothy Patricia Schafer · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · NS

Increasing sensitivity to enviromental stress by humanizing NOS2 in mouse

$478,205
Carol A Colton · Duke University · RC1 · FY2009 · ES

Circumventing the pharmacokinetic/pharmacodynamic limitations of antioxidant therapy for Parkinson's Disease by nose to brain delivery of N-acetylcysteine

$478,165
Douglas Greene · Neuronasal Inc · R41 · FY2024 · AG

Multi-Omics Core

$478,153
Junmin Peng · Mayo Clinic Jacksonville · U19 · FY2024 · AG

Development of Mouse Models of PD

$478,143
Jie Shen · Brigham And Women'S Hospital · P50 · FY2006 · NS

Nonneuronal Mechanisms of Polyglutamine Neurodegeneration

$477,978
Hayley Sarah McLoughlin · University Of Michigan At Ann Arbor · R01 · FY2021 · NS

Regulation of Translation by O-GlcNAc - Resubmission 03-05-2020

$477,898
Gerald Warren Hart · University Of Georgia · R01 · FY2024 · DK

BEHAVIORAL CHARACTERIZATION OF ACUTE&CHRONIC AMPHETAMINE

$477,820
University Of California San Diego · R01 · FY2003 · DA

Mitochondria: controllers of trauma-induced secondary neurodegeneration onset

$477,794
Tonia S Rex · Vanderbilt University Medical Center · R01 · FY2024 · EY

Role of the microglial immune-oxysterol 25-hydroxycholesterol in mediating neuroinflammation and neurodegeneration in the P301S tau transgenic mouse model of Alzheimer's disease

$477,725
Anil G Cashikar · Washington University · R01 · FY2023 · AG